A Phase II Study of Adjuvant Carboplatin and Weekly Paclitaxel in Patients with Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer
Phase 2
- Conditions
- on-small-cell lung cancer
- Registration Number
- JPRN-UMIN000003586
- Lead Sponsor
- Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) active interstitial pneumonitis determined by chest CT 2) active infection or gastric ulcer 3) drug allergy against polyoxethylated castor oil 4) active concomitant malignancy 5) severe complications (i.e. heart diseases required treatment, myocardial infarction within 6 months, liver cirrhosis) 6) pregnant or lactating women 7) severe drug allergy 8) other conditions not suitable for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method